Accessibility issues in cancer care

Research identifies issues with booking new appointments at clinics for cancer treatment

3:48 PM

Author | Tessa Roy

cancer cell blue yellow
Jacob Dwyer, Justine Ross, Michigan Medicine

Researchers at the University of Michigan are finding that many patients may be encountering significant barriers to cancer care, even from their first phone call to a clinic. 

Patients attempting to access cancer care must go through several different levels of communication, both before their initial appointment with a physician and throughout their treatment. 

Making those first calls to learn more about available cancer care services or to schedule an appointment at a clinic is an important step toward beginning their treatment journey.  

“Racial and ethnic disparities have been observed in the outpatient visit rates for specialist care, including cancer care. However, we know very little about patients’ experiences at the critical step of attempting to access new clinic appointments for cancer care,” said Debbie Chen, M.D. 

Researchers set up simulated patient calls and studied whether each caller was able to access cancer care – that meant whether the caller was provided with a clinic appointment date or scheduling information. 

Using standardized scripts, the simulated patients spoke in one of three languages – English, Spanish, or Mandarin – and inquired about a new clinic appointment for colon, lung, or thyroid cancer care. 

The simulated patients called 479 clinic phone numbers, which were provided by the hospital general information staff at 143 hospitals in 12 states.  

Researchers found that access to new patient appointments for cancer care was poor for all simulated patient callers in the study – only 41.5% of the 985 total calls were successful. 

Even the simulated English-speaking patient caller encountered challenges and were successful in accessing cancer care in only 61% of calls. 

About one-quarter of the 985 calls ended early due to workflow barriers, which included calls going to a voicemail that did not provide adequate information, or being on hold for over half an hour.  

In addition, researchers found that access to new patient appointments for cancer care was worse for non-English speaking patients. 

The simulated Spanish- and Mandarin- speaking patient callers accessed cancer care in only 36% and 19% of the calls, respectively, far less than their English-speaking counterpart. 

Nearly 50% of the calls made in Spanish or Mandarin ended due to language barriers when simulated patient callers were hung up on in response to asking “Speak Spanish?” or “Speak Chinese?”, or disconnected when the automated message did not provide language-specific instructions but required input to continue. 

Even after getting connected to interpreter services, some callers were unable to receive further assistance.  

"Our study highlights existing barriers that patients may encounter when attempting to access a new clinic appointment for cancer care and illustrates how this access point functions as a gatekeeper to cancer care services, with many patient populations, including patients with limited English proficiency, unable to even get in the door to see a physician for their cancer care” Chen said. 

Thus, interventions focused on mitigating these barriers are necessary to increase access to cancer care for all patients.

This study was supported by the University of Michigan Rogel Cancer Center (Discovery Award to Dr Chen), National Institute of Diabetes and Digestive and Kidney Diseases (grant No. T32DK007245 to Dr Chen), and National Cancer Institute (grant No. K08CA273047 to Dr Chen).

The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Paper cited: “Access to New Clinic Appointments for Patients With Cancer,” JAMA. DOI: 10.1001/jamanetworkopen.2024.15587

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.


More Articles About:

Cancer Research All Research Topics Cancer Care
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

close up of cells blue purple pink
Health Lab

Researchers create new path to target hard-to-drug prostate cancer protein

University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.
team standing around person using virtual reality headset
Health Lab

How new care models, within a new building launch, are helping optimize patient care

New care models in a new building opening at Michigan Medicine is helping to optimize patient care.
Health Lab

Path forward for glioblastoma treatment

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
lights scattered all over blue screen connected
Health Lab

Studying neurons using neurons

Labs at the University of Michigan Medical School are exploring a new technology that leverages the biological capabilities of human neurons for artificial intelligence.
woman looking at screen in office clinical area
Health Lab

How AI is helping emergency physicians learn from their patients

How the “Tell Me What Happens Next” initiative is being used by the Department of Emergency Medicine’s new Division of Clinical Informatics using artificial intelligence.
baby with hearing aid on ear looking from side view with blue pacifier in mouth
Health Lab

Research may help better predict outcomes in kids with congenital cytomegalovirus

Two new studies may help researchers and clinicians better understand congenital cytomegalovirus (CMV), the most common infectious cause of birth defects and a leading cause of non-genetic hearing loss in children.